You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Children Diagnosed With Chronic Granulomatous Disease

Not yet recruiting
  • CGD
  • DHR
  • (no location specified)
Sep 15, 2022

Seasonal Influenza, Influenza, Influenza Due to Unspecified Influenza Virus Trial in Antwerpen, Hasselt (MF59C.1-adjuvanted

Completed
Has Results
  • Seasonal Influenza
  • +3 more
  • MF59C.1-adjuvanted subunit influenza vaccine
  • Sub unit, Inactivated, Influenza vaccine
  • Antwerpen, Belgium
  • +1 more
Apr 14, 2021

Allogeneic Stem Cell Transplant Recipient, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in

Withdrawn
  • Allogeneic Stem Cell Transplant Recipient
  • +2 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2020

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Locally Advanced Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in United States

Recruiting
  • Locally Advanced Rectal Adenocarcinoma
  • +8 more
  • Ipilimumab
  • +3 more
  • Anchorage, Alaska
  • +209 more
Jan 24, 2023

Negative Symptom, Schizophrenia, Amisulpride Trial (Amisulpride)

Unknown status
  • Negative Symptom
  • +3 more
  • (no location specified)
Aug 26, 2020

COVID-19 Trial in Taichung (UB-612)

Completed
  • COVID-19
  • UB-612
  • Taichung, Taiwan
    China Medical University Hospital
Feb 11, 2022

Intensive Care Unit Sleep Disruption Trial in Boston (Gabapentin 300 mg PO at 8 PM)

Recruiting
  • Intensive Care Unit Sleep Disruption
  • Gabapentin 300 mg PO at 8 PM
  • Boston, Massachusetts
    Tufts Medical Center
Feb 18, 2022

Hepatitis C in HIV Infected Injection Drug Users (IDUs)

Completed
  • HIV Infection
  • Hepatitis C
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Feb 17, 2022

    Biliary Tract Cancer, Cholangiocarcinoma Trial in Nanjing (SHR-1210+GEMOX)

    Completed
    • Biliary Tract Cancer
    • Cholangiocarcinoma
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital
    Oct 27, 2021

    ART Simplification on Inflammatory Markers in coRis (AIR)

    Completed
    • HIV
    • Number of drugs in the ART regimen
    • Madrid, Spain
      Hospital Ramón y Cajal
    Mar 18, 2022

    Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Sunitinib)

    Completed
    Has Results
    • Renal Cell Carcinoma
    • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
    • +2 more
    • Tucson, Arizona
    • +153 more
    Jan 13, 2022

    Acute Myeloid Leukemia Trial in Shenyang (rhTPO, Decitabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Shenyang, Liaoning, China
      ShengJing Hospital of China Medical University
    May 16, 2022

    Psoriasis Vulgaris Trial in Osijek (Low-Salt Diet)

    Recruiting
    • Psoriasis Vulgaris
    • Low-Salt Diet
    • Osijek, Croatia
      University Hospital Osijek
    Jun 8, 2023

    Vitamin D Deficiency Trial in Galveston (Placebo, 800 IU/day vitamin D supplementation with feedings in the first 28 days after

    Not yet recruiting
    • Vitamin D Deficiency
    • Placebo
    • +2 more
    • Galveston, Texas
      The University of Texas Medical Branch
    Jan 20, 2023

    Infection-responsible Bacterial Resistances in Cirrhotic

    Completed
    • Cirrhosis
    • Bacterial samples from blood or peritoneal liquids
    • Lyon, France
      Croix-Rousse Hospital, Hospices Civils de Lyon
    Mar 18, 2022

    Pneumonia, Pneumococcal Trial in Fajara (Pneumosil, Synflorix)

    Completed
    Has Results
    • Pneumonia, Pneumococcal
    • Pneumosil
    • Synflorix
    • Fajara, Gambia
      Medical Research Council (MRC) Unit, The Gambia
    Jun 30, 2020

    Asthma in Children, Asthma Trial (Blood sample, Expectoration, Nasopharyngeal swab)

    Not yet recruiting
    • Asthma in Children
    • Asthma
    • Blood sample
    • +2 more
    • (no location specified)
    Sep 18, 2023

    Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus (drug, biological, other)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Refractory Chronic Lymphocytic Leukemia
    • Bcl-2 Inhibitor GDC-0199
    • +5 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Oct 29, 2021

    Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • HAIC(FOLFOX)
    • +5 more
    • (no location specified)
    Aug 16, 2022

    Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

    Recruiting
    • Recurrent Acute Leukemia
    • +16 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    The Lymphocyte/Neutrophil Ratio asPrognostic Index for Short

    Completed
    • Covid19
      • Assiut, Egypt
        Assuit University
      Oct 9, 2021

      Melanoma Trial in Worldwide (Nivolumab, Ipilimumab)

      Withdrawn
      • Melanoma
      • Nivolumab
      • Ipilimumab
      • Gilbert, Arizona
      • +117 more
      Mar 17, 2021

      HIV Infection, Bone Loss, Osteopenia Trial in Atlanta (Zoledronic acid)

      Completed
      Has Results
      • HIV Infection
      • +3 more
      • Zoledronic acid
      • Atlanta, Georgia
        Grady Infectious Diseases Clinic (Ponce Center)
      Jun 21, 2018

      Smoldering Multiple Myeloma Trial in Boston, Durham, Cleveland (Hiltonol, Citarinostat, Lenalidomide)

      Recruiting
      • Smoldering Multiple Myeloma
      • Boston, Massachusetts
      • +4 more
      Feb 22, 2021